COMPANY

    HISTORY

    2022
    • 06

      Attraction of USD 4 million Pre-series A

    2021
    • 09

      Certification of LMO (Living Modified Organism) Lab

    • 07

      Acquisition of R&D Center certification

    • 05

      Attraction of USD 1.4 million Seed funding

    • 03

      Establishment of D5 Therapeutics